Cargando…

MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer

Prostate cancer (PCa) is one of the most commonly diagnosed cancers among men worldwide. Despite the presence of accumulated clinical strategies for PCa management, limited prognostic/sensitive biomarkers are available to follow up on disease occurrence and progression. MicroRNAs (miRNAs) are small...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghamlouche, Fatima, Yehya, Amani, Zeid, Yousef, Fakhereddine, Hiam, Fawaz, Jhonny, Liu, Yen-Nien, Al-Sayegh, Mohamed, Abou-Kheir, Wassim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827391/ https://www.ncbi.nlm.nih.gov/pubmed/36608541 http://dx.doi.org/10.1016/j.tranon.2022.101613

Ejemplares similares

Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo
por: Yehya, Amani, et al.
Publicado: (2022)

Tissue-specific cancer stem/progenitor cells: Therapeutic implications
por: Yehya, Amani, et al.
Publicado: (2023)

MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer
por: Chen, Wei-Yu, et al.
Publicado: (2014)

Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development
por: Bahmad, Hisham F., et al.
Publicado: (2021)

Crosstalk between COVID-19 and prostate cancer
por: Bahmad, Hisham F., et al.
Publicado: (2020)

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016)

Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines
por: Daoud, Georges, et al.
Publicado: (2016)

Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms
por: Bilani, Nadeem, et al.
Publicado: (2017)

Berberis libanotica Ehrenb Extract Shows Anti-Neoplastic Effects on Prostate Cancer Stem/Progenitor Cells
por: El-Merahbi, Rabih, et al.
Publicado: (2014)

MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012)

microRNAs and prostate cancer
por: Shi, Xu-Bao, et al.
Publicado: (2008)

Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
por: Tsai, Yuan-Chin, et al.
Publicado: (2018)

Epidermal Growth Factor Is Essential for the Maintenance of Novel Prostate Epithelial Cells Isolated From Patient-Derived Organoids
por: Cheaito, Katia, et al.
Publicado: (2020)

Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010)

Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells
por: Bahmad, Hisham F., et al.
Publicado: (2018)

Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency
por: Wen, Yu-Ching, et al.
Publicado: (2022)

MicroRNAs Associated with Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2011)

The role of microRNAs in prostate cancer progression
por: Lo, U-Ging, et al.
Publicado: (2013)

Targeting MicroRNAs in Prostate Cancer Radiotherapy
por: Ni, Jie, et al.
Publicado: (2017)

Role of MicroRNAs in Neuroendocrine Prostate Cancer
por: Sreekumar, Amritha, et al.
Publicado: (2022)

Establishment and characterization of prostate organoids from treatment-naïve patients with prostate cancer
por: Cheaito, Katia, et al.
Publicado: (2022)

Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside
por: Gogola, Samantha, et al.
Publicado: (2023)

MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma
por: Zhang, Hui, et al.
Publicado: (2018)

Identification of microRNAs associated with glioma diagnosis and prognosis
por: Ye, Xinyun, et al.
Publicado: (2017)

Molecular assays for the detection of microRNAs in prostate cancer
por: Siva, Amara C, et al.
Publicado: (2009)

Recent updates on the role of microRNAs in prostate cancer
por: Hassan, Oudai, et al.
Publicado: (2012)

MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle
por: Narayanan, Ramesh, et al.
Publicado: (2010)

AB003. Urinary microRNAs of prostate cancer
por: Kim, Wun-Jae
Publicado: (2016)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

Role of MicroRNAs in Treatment Response in Prostate Cancer
por: Razdan, Anshuli, et al.
Publicado: (2018)

MicroRNAs or Long Noncoding RNAs in Diagnosis and Prognosis of Coronary Artery Disease
por: Zhang, Yuan, et al.
Publicado: (2019)

MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data
por: Rana, Sharmila, et al.
Publicado: (2022)

Self-Renewing Pten(-/-)TP53(-/-) Protospheres Produce Metastatic Adenocarcinoma Cell Lines with Multipotent Progenitor Activity
por: Abou-Kheir, Wassim, et al.
Publicado: (2011)

Computational methods for ab initio detection of microRNAs
por: Allmer, Jens, et al.
Publicado: (2012)

MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis
por: Mallick, Reema, et al.
Publicado: (2010)

microRNAs and next generation sequencing for the prognosis of the metastatic melanoma
por: Pinto, Rosamaria, et al.
Publicado: (2015)

Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma
por: Soliman, Amro M., et al.
Publicado: (2020)

MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers
por: Sharma, Prakash Chand, et al.
Publicado: (2020)

Modeling Adipogenesis: Current and Future Perspective
por: Bahmad, Hisham F., et al.
Publicado: (2020)

Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance
por: Siu, Man Kit, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tm3363qg6csvnsipbf2ppj1c99